Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.
about
Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.
@en
Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.
@nl
type
label
Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.
@en
Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.
@nl
prefLabel
Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.
@en
Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.
@nl
P2093
P2860
P356
P1433
P1476
Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro
@en
P2093
Akiko Chiba
Jorge G Gomez-Gutierrez
Kelly M McMasters
Lacey R McNally
Roberto Montes de Oca-Luna
Roxana Gonzalez-Ramos
P2860
P356
10.3390/CANCERS10050144
P577
2018-05-17T00:00:00Z